Connect Biopharma Files 8-K
Ticker: CNTB · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1835268
Sentiment: neutral
Topics: 8-K, disclosure, corporate-info
TL;DR
Connect Biopharma filed an 8-K on 7/9/25. Offices in San Diego.
AI Summary
Connect Biopharma Holdings Ltd. filed an 8-K on July 9, 2025, reporting on various events. The filing indicates the company's principal executive offices are located at 3580 Carmel Mountain Road, Suite 200, San Diego, California. The report is filed under the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing provides official updates and disclosures from Connect Biopharma Holdings Ltd. to the SEC, which are important for investors to stay informed about the company's status and operations.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting basic company information and office locations, with no immediate indication of significant financial or operational changes.
Key Players & Entities
- Connect Biopharma Holdings Ltd (company) — Registrant
- July 9, 2025 (date) — Date of earliest event reported
- 3580 Carmel Mountain Road, Suite 200 (location) — Address of Principal Executive Offices
- San Diego, California (location) — City and State of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on events relevant to Connect Biopharma Holdings Ltd.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on July 9, 2025.
Where are Connect Biopharma Holdings Ltd.'s principal executive offices located?
The principal executive offices of Connect Biopharma Holdings Ltd. are located at 3580 Carmel Mountain Road, Suite 200, San Diego, California.
What is the company's Standard Industrial Classification (SIC) code?
The company's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding Connect Biopharma Holdings Ltd (CNTB).